Related Experiment Video
Updated: Jul 2, 2026

08:48
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
3.0K
Comprehensive Biotechnical System for Screening Risk-based Diagnosis of COVID-19 and Post-COVID Syndrome
Vladimir Savostyanov1, Alexander Kobelev1, Ivan Kudashov1
1Faculty of Biomedical Engineering, Bauman Moscow State Technical University, Moscow, Russia.
Journal of Electrical Bioimpedance
|October 5, 2022
Summary
A new biotechnical system uses transthoracic electrical impedance rheography to assess post-COVID syndrome severity in vivo. It identifies physiological signs of latent complications, enabling personalized rehabilitation programs.
Area of Science:
- Biomedical Engineering
- Cardiovascular Physiology
- Post-COVID Syndrome Research
Background:
- Current methods for assessing post-COVID syndrome severity in vivo are lacking.
- Objective measurement of physiological parameters is crucial for effective diagnosis and management.
Purpose of the Study:
- To develop and validate a novel biotechnical system for in vivo assessment of post-COVID syndrome severity.
- To identify reliable physiological markers indicative of latent post-COVID complications.
Main Methods:
- Utilizing transthoracic electrical impedance rheography (TEIR) to record bioimpedance responses to controlled stress.
- Analyzing frequency characteristics of bioimpedance to evaluate cardiac function, hemomicrocirculation, and gas transport.
- Employing a neural network for mathematical approximation and ranking of biometric data.
Main Results:
- The system successfully assesses cardiac productivity, hemomicrocirculatory status, and blood gas transport.
- Two key physiological signs of latent post-COVID complications were identified: decreased base impedance with light exercise and increased systolic arc length on rheocardiograms.
- The system enables automatic generation of personalized medical rehabilitation programs.
Conclusions:
- The proposed biotechnical system offers a non-invasive method for in vivo assessment of post-COVID syndrome.
- Identified physiological signs provide reliable indicators of subclinical post-COVID conditions.
- This technology facilitates personalized rehabilitation strategies for patients with post-COVID syndrome.

